CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016

Similar Companies

HepaHope

HepaHope is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TVA Medical

TVA Medical, Inc. is a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease (ESRD). The company was founded by Dr. William Cohn in partnership with Sante Ventures, a life sciences venture capital firm based in Austin, TX.

Newport Medical Instruments

Newport Medical Instruments, Inc. is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orthodontic Supply of Canada

Orthodontic Supply of Canada is a Lincoln, NB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Laboratory Specialists

Laboratory Specialists is a Toledo, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.